EPCAM and familial pancreatic carcinoma: The results also emphasized that utilizing both epithelial (EpCAM) and mesenchymal (vimentin) antibodies with the lateral magnetophoretic microseparator significantly enhanced CTC isolation efficiency for both prostate and pancreatic cancer patients.